Chris MacDonald

Chris MacDonald

InvestorPlace Contributor

Chris MacDonald is an MBA (finance) graduate with extensive experience covering small-, mid- and large-cap companies in the U.S. and Canadian markets. Chris is interesting in uncovering long-term and deep-value opportunities for investors based on principles from the Graham-Buffett school of thought, and looks forward to bringing investors a unique fundamental-based perspective on opportunities available in today’s challenging investing environment.

His experience as a financial analyst in the past, coupled with his fervor for finding undervalued growth opportunities, contribute to his conservative, long-term investing perspective.

Recent Articles

MVIS Stock: The Short Squeeze Powering 40% Gains Today

By Chris MacDonald, InvestorPlace Contributor

Today, it appears MVIS stock has earned its unofficial "meme stock" status as a short-squeeze candidate among social media-savvy investors.

GNUS Stock: 2 Big Catalysts Lifting Genius Brands Today

By Chris MacDonald, InvestorPlace Contributor

Today, GNUS stock is soaring higher as investors price in a couple of bullish catalysts into this digital media stock.

RVPH Stock: Why Reviva Pharmaceuticals Is Skyrocketing 90% on Monday

By Chris MacDonald, InvestorPlace Contributor

Today, investors in RVPH stock saw some pretty massive gains, as the company announced impressive results for its schizophrenia drug.

AMC Still Isn’t a Buy After CEO Says it Won’t Issue Shares This Year

By Chris MacDonald, InvestorPlace Contributor

Here's why I think AMC stock isn't worth more than $5 per share today, let alone anywhere close to the $10 per share level it's trading at.

CCIV Stock: The Speculation That Has Churchill Capital Racing Higher Today

By Chris MacDonald, InvestorPlace Contributor

Today, shareholders in CCIV stock are seeing some pretty impressive gains as rumors begin to build about a potential Apple partnership.

Why Investors Might Want to Start Getting Bullish on Ocugen

By Chris MacDonald, InvestorPlace Contributor

As the vaccine rollout accelerates, investors remain on the fence as to how the Covaxin vaccine will impact OCGN stock in the near term.

The Value Proposition of AI Stock Is Intriguing for Growth Investors

By Chris MacDonald, InvestorPlace Contributor

Investors focused on growth may want to consider the unique artificial intelligence offering AI stock provides right now.

Why Pershing Square Tontine Could Be Put In the Penalty Box

By Chris MacDonald, InvestorPlace Contributor

Investors in PSTH stock have seen some pretty consistent selling pressure of late as they eagerly await an announced merger partner.

Top Stocks 2021: If You Only Buy One AI Stock, It Better Be C3.ai

By Chris MacDonald, InvestorPlace Contributor

Here's why I'd recommend investors looking at artificial intelligence stocks to consider AI stock in this current environment.

Holo: An Interesting Paradigm Shift Away From Blockchain

By Chris MacDonald, InvestorPlace Contributor

Here's a breakdown of why this cryptocurrency option is gaining so much traction now and what Holo can offer intrigued investors.

Load More